Clinical Trial Update: A Study to Assess the Effect of CC-95251 in Participants With Acute Myeloid Leukemia and Myelodysplastic Syndromes [Phase 1]

View source ↗

Summary

This Phase 1 trial update reports results for CC-95251 in acute myeloid leukemia and myelodysplastic syndromes. The study has been terminated and results have b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• CC-95251

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Leukemia, Myeloid, Acute, Myelodysplastic Syndromes | Phase 1 | Status: TERMINATED | Results posted: 2025-09-25